Human nitrosamine exposure: recent dosimetry methods and applications.
Bartsch
H
H
International Agency for Research on Cancer, Lyon, France.
Shuker
D E
DE
Ohshima
H
H
D000225:Adenine / Q000031:analogs & derivatives / Q000652:urine; D015415:Biomarkers; D002273:Carcinogens / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000633:toxicity; D004249:DNA Damage; D006801:Humans; D009602:Nitrosamines / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics / Q000652:urine; D009603:Nitroso Compounds / Q000493:pharmacokinetics; D014443:Tyrosine / Q000031:analogs & derivatives / Q000378:metabolism
D015415:Biomarkers; D002273:Carcinogens; D009602:Nitrosamines; D009603:Nitroso Compounds; C002744:3-nitrotyrosine; D014443:Tyrosine; C025946:3-methyladenine; C010259:nitrosoproline; D000225:Adenine